Comorbidity of Depression and Anxiety: Association with Poor Quality of Life in Type 1 and 2 Diabetic Patients
Tóm tắt
Diabetes is associates with depression and impairment in Quality of Life (QoL).
The objective is to define the frequencies of depressive and anxiety symptoms in a sample of patients diagnosed with type 1 and 2 diabetes, the amount of impairment of QoL and the weight of depression and anxiety in determining the QoL in such of patients.
A total of 210 patients were divided into two groups (type 1 and type 2). Patients completed the HADS and WHOQoL-bref.
Groups showed a high prevalence of anxiety (type 1 = 60%, type 2 = 43.8%) and depression (type 1 = 52.4%, type 2 = 38.1%), both measures were significantly higher (p < 0.05) in diabetes type 1 patients. Type 1 patients also showed a QoL in the overall assessment and the physical, psychological and social relations domains. In both Type 1 and 2 diabetes poor QoL was found associated by anxiety and depression comorbidity.
In overall diabetes patients depression and anxiety seems to be a determinant of poor QoL.
Từ khóa
Tài liệu tham khảo
Eaton WW, Mengel M, Mengel L, Larson D, Campbell R, Montague RB. Psychosocial and psychopathologic influences on management and control of insulin-dependent diabetes Int J Psychiatry Med 1992; 22 (2) : 105-7.
Tulloch-Reid MK, Walker SP. Quality of life in Caribbean youth with diabetes West Indian Med J 2009; 58 (3) : 250-6.
Rodrigo OM, Ana PRLA, Hugo RB, et al. Depressive symptoms and quality of life in type 2 diabetic patients with diabetic distal polyneuropathy Arq Bras Endocrinol Metabol 2009; 53 (9) : 1103-.
Green AJ, Bazata DD, Fox KM, Grandy S. Quality of Life, Depression, and Healthcare Resource Utilization among Adults with Type 2 Diabetes Mellitus and Concomitant Hypertension and Obesity: A Prospective Survey Cardiol Res Pract 2012; 2012 : 404107.
Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs Arch Intern Med 2000; 160 (21) : 3278-85.
Lewko J, Kochanowicz J, Zarzycki W, Mariak Z, Górska M, Krajewska-Kulak E. Poor hand function in diabetics. Its causes and effects on the quality of life Saudi Med J 2012; 33 (4) : 429-35.
Wang MY, Tsai PS, Chou KR, Chen CM. A systematic review of the efficacy of non-pharmacological treatments for depression on glycaemic control in type 2 diabetics J Clin Nurs 2008; 17 (19) : 2524-30.
Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes Diabet Med 2009; 26 (2) : 153-61.
Asche CV, Bode B, Busk AK, Nair S. The Economic and Clinical Benefits of Adequate Insulin Initiation and Intensification in People with Type 2 Diabetes Mellitus Diabetes Obes Metab 2012; 14 (1) : 47-57.
Mantovani G, Astara G, Lampis B, et al. Impact of psychosocial interventions on quality of life of elderly cancer patients Psycho oncol 1996; 5 : 127-35.
Mura G, Bhat KM, Pisano A, Licci G, Carta M. Psychiatric symptoms and quality of life in systemic sclerosis Clin Pract Epidemiol Ment Health 2012; 8 : 30-5.
Carpiniello B, Piras A, Pariante CM, Carta MG, Rudas N. Psychiatric morbidity and family burden among parents of disabled children Psychiatr Serv 1995; 46 : 940-2.
Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J Clin Psychiatry 1998; 59 : 22-3.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale Acta Psychiatr Scand 1983; 67 : 361-70.
Skevington SM, Lotfy M, O'Connell KA. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group Qual Life Res 2004; 13 : 299-310.
World Health Organization. The World Health Organization Quality of Life assessment (WHOQOL) position paper from the World Health Organization Soc Sci Med 1995; 41 (10) : 1403-9.
World Health Organization. Development of the World Health Organization WHOQOL-Bref Quality of Life Assessment. The WHOQOL Group Psychol Med 1998; 28 : 551-8.
Ormseth MJ, Scholz BA, Boomershine CS. Duloxetine in the management of diabetic peripheral neuropathic pain Patient Prefer Adherence 2011; 5 : 343-56.
Bergh AL, Persson LO, Attvall S. Psychometric properties of the Swedish version of the Well-Being Questionnaire in a sample of patients with diabetes type 1 Scand J Public Health 2000; 28 (2) : 137-45.
Hoffman C, Rice D, Sung HY. Persons with chronic conditions—their prevalence and costs J Am Med Assoc 1996; 276 : 1473-9.
Hornbrook MC, Goodman MJ. Chronic disease, functional health status, and demographics: a multi-dimensional approach to risk adjustment Health Serv Res 1996; 31 : 283-307.
Krousel-Wood MA, Richard N. Health status assessment in a hypertension section of an internal medical clinic Am J Med Sci 1994; 308 : 211-7.
Rosenzweig S, Reibel DK, Greeson JM, et al. Mindfulness-based stress reduction is associated with improved glycemic control in type 2 diabetes mellitus: a pilot study Altern Ther Health Med 2007; 13 (5) : 36-8.
Jahanlou AS, Ghofranipour F, Kimmiagar M, Vafaei M, Heydarnia A, Sobhani A. Can quality of life questionnaires be used in diabetics to assess the relation between HbA1c and patients' domain aspects? Acta Med Iran 2011; 49 (4) : 246-51.
Mosaku K, Kolawole B, Mume C, Ikem R. Depression, anxiety and quality of life among diabetic patients: a comparative study J Natl Med Assoc 2008; 100 (1) : 73-8.
Jimenez-Garcia R, de Miguel-Díez J, Rejas-Gutierrez J, et al. Health, treatment and health care resources consumption profile among Spanish adults with diabetes and chronic obstructive pulmonary disease Prim Care Diabetes 2009; 3 (3) : 141-8.
Chaudhry R, Mishra P, Mishra J, Parminder S, Mishra BP. Psychiatric morbidity among diabetic patients: A hospital-based study Ind Psychiatry J 2010; 19 (1) : 47-9.
Lynch S, Merson S, Beshyah SA, et al. Psychiatric morbidity in adults with hypopituitarism J R Soc Med 1994; 87 (8) : 445-7.
BundóVidiella M, AubàLlambrich J, MassonsCirera J, Trilla Soler MC, Pérez Villegas R, Pérez del Campo AM. Anxiety and depression in type II diabetics Aten Primaria 1996; 17 (1) : 58-62.